IRCT20210201050197N2已完成未知
Single-dose bioequivalence studies of Valsartan (80 mg) in healthy volunteers
Razak Pharmaceutical Company0 个研究点目标入组 26 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Healthy volunteer
- •Age: 18-50 year
排除标准
- •History of liver, kidney and cardiovascular diseases that can affect drug clearance from body
- •History of taking any medication in the last two weeks
- •Creatinine above 2
研究者
相似试验
招募中
不适用
Bioequivalence of Valsartan tabletsIRCT20170717035129N1Hakim Pharmaceutical Company26
招募中
Unknown
Investigating bioequivalence of valsartan tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N15Tabriz University of Medical Sciences24
尚未招募
不适用
Bioequivalence study of Valsartan 160 mg tablet in 24 healthy male under fasting conditionsBioequivalence investigation of the generic Karen Pharma and Food Supplement Co. Valsartan 160 mg tablet with brand Diovan® 160 mg tablet Novartis pharmaceuticals...IRCT20180620040164N18Karen Pharma and Food Supplement Co.24
已完成
不适用
Bioequivalence study of Valsartan 160 mgHealthy volunteers.IRCT20200623047902N5Sanamed pharma company24
尚未招募
不适用
Bioeqivalence study of amlodipine valsartan 10/160 mg tabletBioequivalence study.IRCT20220209053979N5Alborz Darou24